NCT04416152

Brief Summary

To get the impact of pelvic floor reconstruction surgery on lower urinary tract symptoms, psychological distress and sexual function.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 26, 2020

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

June 1, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 4, 2020

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

September 15, 2023

Status Verified

September 1, 2023

Enrollment Period

4.6 years

First QC Date

June 1, 2020

Last Update Submit

September 14, 2023

Conditions

Outcome Measures

Primary Outcomes (5)

  • the women's bladder function questionnaire of UDI-6

    Change of UDI-6 score between baseline and after pelvic reconstruction surgery. Score values 0-18, and higher scores mean a or worse outcome.

    10 years

  • the women's bladder function questionnaire of IIQ-7

    Change of IIQ-7 score between baseline and after pelvic reconstruction surgery. Score values 0-18, and higher scores mean a or worse outcome.

    10 years

  • Change of psychosomatic score

    Change of psychosomatic score between baseline and after pelvic reconstruction surgery, and higher scores mean a or worse outcome.

    1 year

  • Change of Overactive Bladder Symptom Score

    Change of OABSS score between baseline and after pelvic reconstruction surgery. Score values 0-15, and higher scores mean a or worse outcome.

    1 year

  • Change of FSFI score

    Change of FSFI score between baseline and after pelvic reconstruction surgery. higher scores mean a or worse outcome.

    1 year

Interventions

Pelvic reconstruction surgeries, such as anterior/posterior colporrhaphy, sacrospinous ligament fixation, transvaginal mesh repair and sacrocolpopexy.

Eligibility Criteria

Age20 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women with pelvic organ prolapse, who will undergo or had undergo pelvic reconstruction surgeries.

You may qualify if:

  • Women with pelvic organ prolapse, who will undergo pelvic reconstruction surgery
  • Women who had undergone pelvic reconstruction surgeries in our hospital

You may not qualify if:

  • Pregnant woman.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Far Eastern Memorial Hospital

Banqiao District, New Taipei, 22050, Taiwan

RECRUITING

MeSH Terms

Conditions

Pelvic Organ Prolapse

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Central Study Contacts

Sheng-Mou Hsiao, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Department of Obstetrics & Gynecology, Far Eastern Memorial Hospital

Study Record Dates

First Submitted

June 1, 2020

First Posted

June 4, 2020

Study Start

May 26, 2020

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

September 15, 2023

Record last verified: 2023-09

Locations